|
Contact
Information:
Laura
Brockway
978.232.6057
laura.brockway@thermo.com
Thermo
Electron Corporation and Block Scientific, Inc Offer Full
Service for your Clinical Lab
Beverly,
Massachusetts (May 7, 2004,) – Thermo Electron Corporation
(NYSE:TMO) and Block Scientific, Inc. have joined together
to offer premium quality ALKO Clinical Consumables and equipment
for a total lab solution.
The
Lab Solution packages include instrumentation, consumables,
parts and service for a broad range of Blood Gas, Electrolyte
(ISE) and Chemistry (ISE) analyzers. The analyzers supported
by both companies include those manufactured by Bayer (Chiron),
Beckman, IL, Olympus, Radiometer, Roche AVL and Roche/Hitachi*.
For
further details, please visit www.thermo.com/clinicalconsumables
or www.blockscientific.com. Thermo Electron and Block Scientific
will be pleased to work with each laboratory to suit specific
product and instrumentation needs.
* Thermo Electron Corporation and Block Scientific Inc. expressly
disclaim any affiliation with or sponsorship by the companies
referred to above.
About
Clinical Consumables
ALKO Blood Gas and Electrolyte Products from Thermo Electron
are manufactured under FDA Quality System Regulations. The
company’s line of products includes calibrators, accessory
solutions, electrodes, accessories and quality controls for
use on over 130 clinical instruments. Thermo Electron also
offers Cytology/Histology Products from Lerner Laboratories
and HPLC Products from Chromsystems.
About
Thermo Electron
Leading
the world in high-tech instruments, Thermo Electron Corporation
helps life science, laboratory, and industrial customers advance
scientific knowledge, enable drug discovery, improve manufacturing
processes, and protect people and the environment with instruments,
scientific equipment, and sample-in/knowledge-out solutions.
Based in Waltham, Massachusetts, Thermo Electron has revenues
of more than $2 billion, and employs approximately 11,000
people in 30 countries worldwide. For more information, visit
www.thermo.com.
The
following constitutes a “Safe Harbor” statement under the Private Securities Litigation
Reform Act of 1995. This press release contains
forward-looking statements that involve
a number of risks and uncertainties. Important
factors that could cause actual results
to differ materially from those indicated
by such forward-looking statements are set
forth under the heading “Forward-Looking
Statements” in our Annual Report on
Form 10-K for the fiscal year ended December
28, 2002. These include risks and uncertainties
relating to the need to develop new products
and adapt to significant technological change,
dependence on customers that operate in
cyclical industries, general worldwide economic
slow down and related uncertainties, the
effect of changes in governmental regulations,
dependence on customers’ capital spending
policies and government funding policies,
use and protection of intellectual property,
retention of contingent liabilities from
businesses we sold, integration and consolidation
of our instrument businesses, realization
of potential future savings from new sourcing
initiatives, implementation of new branding
strategy, implementation of strategies for
improving internal growth, the effect of
exchange rate fluctuations on international
operations, and potential impairment of
goodwill. We undertake no obligation to
publicly update any forward-looking statement,
whether as a result of new information,
future events, or otherwise.
|
